Business Description
Albert Labs International Corp
NAICS : 541714
SIC : 3741
ISIN : CA0127841041
Compare
Compare
Traded in other countries / regions
ABRT.CanadaVB50.Germany IPO Date
2022-03-10Description
Albert Labs International Corp is a laboratory-based, clinical research and drug development enterprise addressing mental health care needs. The company is focusing on Real World Evidence (RWE) the company will initially look to commercialize its mycelium-based KRN-101 medicine and treatment with the help of clinical pathway.
Financial Strength
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Equity-to-Asset | -6.82 | |||||
| Debt-to-Equity | -0.02 | |||||
| Debt-to-EBITDA | 0.02 | |||||
| Interest Coverage | N/A |
N/A
|
N/A
| |||
| Piotroski F-Score | N/A/9 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History |
|---|
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 55.26 | |||||
| 9-Day RSI | 52.16 | |||||
| 14-Day RSI | 52.18 | |||||
| 6-1 Month Momentum % | 200 | |||||
| 12-1 Month Momentum % | -72.73 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 0.03 | |||||
| Quick Ratio | 0.03 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Shareholder Yield % | -29.57 |
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| ROA % | -1085.14 | |||||
| ROIC % | -1075.46 | |||||
| ROC (Joel Greenblatt) % | 944.27 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| EV-to-EBIT | 1.85 | |||||
| EV-to-EBITDA | 1.8 | |||||
| EV-to-FCF | -2.28 | |||||
| Earnings Yield (Greenblatt) % | 54.05 | |||||
| FCF Yield % | -44.18 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Albert Labs International Corp Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil C$) | |||
| EPS (TTM) (C$) | -0.052 | ||
| Beta | 0 | ||
| Volatility % | 139.31 | ||
| 14-Day RSI | 52.18 | ||
| 14-Day ATR (C$) | 0.000771 | ||
| 20-Day SMA (C$) | 0.015 | ||
| 12-1 Month Momentum % | -72.73 | ||
| 52-Week Range (C$) | 0.005 - 0.055 | ||
| Shares Outstanding (Mil) | 74.41 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 9999 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Albert Labs International Corp Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Albert Labs International Corp Stock Events
| Event | Date | Price(C$) | ||
|---|---|---|---|---|
| No Event Data | ||||
Albert Labs International Corp Frequently Asked Questions
What is Albert Labs International Corp(XCNQ:ABRT)'s stock price today?
The current price of XCNQ:ABRT is C$0.02. The 52 week high of XCNQ:ABRT is C$0.06 and 52 week low is C$0.01.
When is next earnings date of Albert Labs International Corp(XCNQ:ABRT)?
The next earnings date of Albert Labs International Corp(XCNQ:ABRT) is 2024-05-30 Est..
Does Albert Labs International Corp(XCNQ:ABRT) pay dividends? If so, how much?
Albert Labs International Corp(XCNQ:ABRT) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers